Moreover, there was no significant decrease in the AFP levels of CHB‐HCC patients with HBeAg‐ or with cirrhosis compared to patients with HBeAg+ or with cirrhosis (P > .05) (Figure 4G‐I). Here, AFP is linked to hepatocellular carcinoma.